News & Publications

Clinical Research

Contains posts about clinical research

Jan
18

Biologically Inspired, Cell‐Selective Release of Aptamer‐Trapped Growth Factors by Traction Forces

Biomaterial scaffolds that are designed to incorporate dynamic, spatiotemporal information have the potential to interface with cells and tissues to direct behavior. Here, a bioinspired, programmable nanotechnology‐based platform is described that harnesses cellular traction forces to activate growth factors, eliminating the need for exogenous triggers (e.g., light), spatially diffuse triggers (e.g., enzymes, pH changes), or passive activation (e.g., hydrolysis).

Read More
Dec
14

A national analysis of readmissions for wound healing complications following the repair of lower back, hip, and buttock pressure ulcers using the Nationwide Readmissions Database

Traditionally, a 30-day postoperative period is used to assess outcomes in surgery. However, it is not clear if this is sufficient. Our study assessed readmissions and their risk factors following the surgical repair of pressure ulcers in a 90-day postoperative period.

Read More
Dec
14

SANUWAVE Announces Peer Review Article Published in Journal of Wound Care (Dec. 2018): Extracorporeal Shock Wave Technology (ESWT) as Compared to Standard of Care in DFUs

SANUWAVE Health, Inc. an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, announces the publication of the research that investigated the effects of dermaPACE® System (an Extracorporeal Shock Wave Technology (ESWT)) compared with Standard of Care in Diabetic Foot Ulcers (DFUs).

Read More
Dec
3

Treatment of Refractory Diabetic Foot Ulcers Improved With LeucoPatch

In patients with diabetes who have hard-to-heal foot ulcers, a clinically and statistically significant benefit has been associated with the weekly application of autologous leukocytes, fibrin, and platelet patches (LeucoPatch), according to the results of a multicenter, randomized, controlled trial (ClinicalTrials.gov identifier: NCT02224742) published in The Lancet Diabetes & Endocrinology.

Read More